PT2948179T - Composições que compreendem nanopartículas de óxido de háfnio (iv) ou óxido de rénio (iv) em combinação com radiações ionizantes para tratamento do câncro - Google Patents

Composições que compreendem nanopartículas de óxido de háfnio (iv) ou óxido de rénio (iv) em combinação com radiações ionizantes para tratamento do câncro

Info

Publication number
PT2948179T
PT2948179T PT14701965T PT14701965T PT2948179T PT 2948179 T PT2948179 T PT 2948179T PT 14701965 T PT14701965 T PT 14701965T PT 14701965 T PT14701965 T PT 14701965T PT 2948179 T PT2948179 T PT 2948179T
Authority
PT
Portugal
Prior art keywords
oxide
rhenium
hafnium
nanoparticles
compositions
Prior art date
Application number
PT14701965T
Other languages
English (en)
Portuguese (pt)
Inventor
Borghi Elsa
Levy Laurent
Pottier Agnès
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of PT2948179T publication Critical patent/PT2948179T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT14701965T 2013-01-25 2014-01-24 Composições que compreendem nanopartículas de óxido de háfnio (iv) ou óxido de rénio (iv) em combinação com radiações ionizantes para tratamento do câncro PT2948179T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361756533P 2013-01-25 2013-01-25
EP13305087 2013-01-25

Publications (1)

Publication Number Publication Date
PT2948179T true PT2948179T (pt) 2019-07-19

Family

ID=67296872

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14701965T PT2948179T (pt) 2013-01-25 2014-01-24 Composições que compreendem nanopartículas de óxido de háfnio (iv) ou óxido de rénio (iv) em combinação com radiações ionizantes para tratamento do câncro

Country Status (9)

Country Link
DK (1) DK2948179T3 (es)
ES (1) ES2734493T3 (es)
HR (1) HRP20191272T1 (es)
HU (1) HUE045407T2 (es)
LT (1) LT2948179T (es)
NZ (2) NZ709685A (es)
PT (1) PT2948179T (es)
SG (1) SG10202105500VA (es)
TR (1) TR201910251T4 (es)

Also Published As

Publication number Publication date
NZ709685A (en) 2019-10-25
HUE045407T2 (hu) 2019-12-30
HRP20191272T1 (hr) 2019-10-18
TR201910251T4 (tr) 2019-07-22
LT2948179T (lt) 2019-08-12
SG10202105500VA (en) 2021-07-29
DK2948179T3 (da) 2019-07-22
NZ750194A (en) 2020-02-28
ES2734493T3 (es) 2019-12-10

Similar Documents

Publication Publication Date Title
PL2948179T3 (pl) Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu
IL276428A (en) A preparation and vaccine for the treatment of lung cancer
IL273090B (en) Methods and preparations for the treatment of cancer
IL245281A0 (en) Methods and preparations for the treatment of cancer
SG10201801433XA (en) Composition and vaccine for treating prostate cancer
HK1225647A1 (zh) 用於治療癌症的組合物和方法
EP3004395A4 (en) Compositions and methods for treating cancer
PL3071192T3 (pl) Związek kurkufenol do zastosowania w leczeniu nowotworu
IL246065A0 (en) Valiprib in combination with carboplatin for the treatment of triple negative breast cancer
EP2984185A4 (en) Methods and compositions for treating cancer
HUE045407T2 (hu) Hafnium(IV)-oxid vagy rénium(IV)-oxid vagy nanorészecskéket tartalmazó készítmények ionizáló sugarakkal kombinálva, rák kezelésére
EP2971044A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
PL3035955T3 (pl) Kompozycja i szczepionka do leczenia raka płuca
EP2968398A4 (en) MODIFIED HYALURONAN AND USES THEREOF IN CANCER TREATMENT
GB201322958D0 (en) Uses of oligouronates in cancer treatment